From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
Category: Meetings
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay...
The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR,...
Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents...
At the AACR Annual Meeting 2026, we conducted "Bite-sized Research" interviews with attendees for morsels of knowledge about their...
Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer...
At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...
At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people...
The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology...
In the CAR-PRISM clinical trial, the CAR T-cell therapy ciltacabtagene autoleucel showed promise for treating high-risk smoldering myeloma.